---
figid: PMC9398498__10120_2022_1332_Fig7_HTML
pmcid: PMC9398498
image_filename: 10120_2022_1332_Fig7_HTML.jpg
figure_link: /pmc/articles/PMC9398498/figure/Fig7/
number: Fig. 7
figure_title: ''
caption: The mechanism of SPK1/S1P pathway in IM-resistance cells. A, B The cell cycle
  of GIST-T1 and GIST-T1/IMR after the treatment of IM and DMS with IM. C–E. The cell
  apoptosis rate of GIST-T1 and GIST-T1/IMR after the treatment of IM and DMS with
  IM, respectively. F–I. S1P, SPK1 and ABCC1 protein expression via western blot assay
article_title: SPK1/S1P axis confers gastrointestinal stromal tumors (GISTs) resistance
  of imatinib.
citation: Yan Chen, et al. Gastric Cancer. 2022 Aug 24 ;26(1):26-43.
year: '2022'

doi: 10.1007/s10120-022-01332-7
journal_title: Gastric Cancer
journal_nlm_ta: Gastric Cancer
publisher_name: Springer Nature Singapore

keywords:
- Therapeutic drug monitoring
- OCT1 genetic polymorphisms
- Drug resistance
- Sphingolipid metabolism
- SPK1/S1P axis

---
